Home > News > NCL to go into labs with ‘Golden Triangle’ for cancer trials
May 30th, 2005
NCL to go into labs with ‘Golden Triangle’ for cancer trials
Eight months after raising hopes with their cutting edge ‘Golden Triangle’ technology for fighting cancer sans chemotherapy, nanoscientists at the National Chemical Laboratory (NCL) are gearing up for the technology’s first in-vitro tests.
The trials are being conducted to establish the toxicity of the gold nano-particles. "While gold is inherently non-toxic, we have to see exactly where the nano-sized triangles go when introduced into the cancerous area. We have kept a two-year window to see if we can get into clinical trials on humans."
National Chemical Laboratory
Untangling DNA with a droplet of water, a pipet and a polymer: With the 'rolling droplet technique,' a DNA-injected water droplet rolls like a ball over a platelet, sticking the DNA to the plate surface February 27th, 2015
Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015
Cutting-edge technology optimizes cancer therapy with nanomedicine drug combinations: UCLA bioengineers develop platform that offers personalized approach to treatment February 24th, 2015
Optical nanoantennas set the stage for a NEMS lab-on-a-chip revolution February 24th, 2015
Scientific breakthrough in rechargeable batteries: Researchers from Singapore and Québec Team Up to Develop Next-Generation Materials to Power Electronic Devices and Electric Vehicles February 28th, 2015
First detailed microscopy evidence of bacteria at the lower size limit of life: Berkeley Lab research provides comprehensive description of ultra-small bacteria February 28th, 2015
Leti to Offer Updates on Silicon Photonics Successes at OFC in LA February 27th, 2015
Moving molecule writes letters: Caging of molecules allows investigation of equilibrium thermodynamics February 27th, 2015